Q2 FY26 results: Standalone PAT up 21%, revenue down 14%; Euro 14M subsidiary investment approved
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 3.0 pts less than its Dyes And Pigments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q2 and H1 FY26 results. Standalone revenue fell 14% YoY in Q2 to 582.5 cr (H1: 1,113.7 cr, down 11%). Standalone PAT rose 21% YoY to 74.1 cr in Q2 (H1: 147.4 cr, up 44%). Consolidated revenue surged to 2,387 cr in Q2 vs 696 cr YoY due to the Heubach Group acquisition completed in March 2025. Consolidated PAT was 19.3 cr with 11.2 cr in exceptional items. Board appointed Sanjay K. Asher as Additional Director and approved up to Euro 14 million further investment in wholly owned subsidiary Sudarshan Europe B.V.
Mixed picture: standalone margins strong but top-line weak; consolidated numbers lifted by Heubach acquisition making YoY comparisons uneven.